Ryosuke Matsukane

Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events

Y. Nakanishi, S. Masuda, I. Okamoto, 2021, Scientific reports.

Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy

Y. Nakanishi, I. Okamoto, I. Ieiri, 2021, Scientific Reports.